WO2025177113 - AN ORODISPERSIBLE TABLET OF SPIRONOLACTONE AND ITS PROCESS OF PREPARATION
National phase entry is expected:
Publication Number
WO/2025/177113
Publication Date
28.08.2025
International Application No.
PCT/IB2025/051309
International Filing Date
07.02.2025
Title **
[English]
AN ORODISPERSIBLE TABLET OF SPIRONOLACTONE AND ITS PROCESS OF PREPARATION
[French]
COMPRIMÉ ORODISPERSIBLE DE SPIRONOLACTONE ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
NOVUMGEN LIMITED
Inventors
PATEL, Kamleshkumar
Priority Data
2402443.2
21.02.2024
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2340 | |
| EPO | Filing, Examination, Granting | 13733 | |
| Japan | Filing, Examination, Granting | 2513 | |
| South Korea | Filing, Examination, Granting | 2719 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
27,245
Contact Us
Abstract[English]
The present invention relates to an orodispersible tablet comprising spironolactone or pharmaceutically acceptable salts thereof, at least one diluent, a disintegrant, a binder, a solubilizer, a lubricant, and one or more pharmaceutically acceptable excipients. The orodispersible tablet of spironolactone or pharmaceutically acceptable salts thereof is formulated for acceptable palatability and taste-masking of the bitter drug, thereby enhancing patient compliance, especially among pediatric and geriatric individuals with dysphagia. The orodispersible tablet of spironolactone is manufactured by the wet granulation method to provide a faster disintegration and dissolution rate of said tablet.[French]
La présente invention concerne un comprimé orodispersible comprenant de la spironolactone ou des sels pharmaceutiquement acceptables de celle-ci, au moins un diluant, un délitant, un liant, un solubilisant, un lubrifiant et un ou plusieurs excipients pharmaceutiquement acceptables. Le comprimé orodispersible de spironolactone ou de sels pharmaceutiquement acceptables de celle-ci est formulé pour une palatabilité acceptable et un masquage de goût du médicament amer, ce qui permet d'améliorer l'observance du patient, en particulier parmi des individus pédiatriques et gériatriques présentant une dysphagie. Le comprimé orodispersible de spironolactone est fabriqué au moyen du procédé de granulation par voie humide pour assurer un taux de désintégration et de dissolution plus rapide dudit comprimé.